Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lamprene

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Clofazimine, a lipophilic (log P = 7.66) riminophenazine antibiotic approved by the US Food and Drug Administration (FDA) with a… Expand
Is this relevant?
2017
2017
Pancreatic ductal adenocarcinoma (PDAC) represents the most common form of pancreatic cancer with rising incidence in developing… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1997
1997
Clofazimine (Lamprene) is an antimycobacterial drug that has antiinflammatory activity in a number of chronic autoimmune skin… Expand
  • table 2
  • table 1
  • table 3
Is this relevant?
1986
1986
Bull's-eye retinopathy has multiple associations. We report a case of bull's-eye retinopathy presumed to be secondary to… Expand
Is this relevant?
1983
1983
A 46-year-old woman with widespread prurigo nodularis was treated with 300 mg clofazimine a day for six months. Ten months after… Expand
Is this relevant?
Review
1981
Review
1981
Several categories of chemical and pharmacologic agents can cause alterations in cutaneous pigmentation, although the mechanisms… Expand
Is this relevant?
1981
1981
We have identified two metabolites of clofazimine (B663; Lamprene; 3-(p-chloroanilino)-10-(p-chlorophenyl)-2,10-dihydro-2… Expand
Is this relevant?
1980
1980
A male patient 68 years, suffering from pyoderma gangrenosum which was resistant to conventional treatment, received clofazimine… Expand
Is this relevant?
Review
1979
Review
1979
 
Is this relevant?
1973
1973
  • Steven E. Bor
  • South African medical journal = Suid-Afrikaanse…
  • 1973
  • Corpus ID: 7006940
Considerable re-pigmentation of vitiliginous skin occurred in 8 White female patients who were treated with clofazimine and… Expand
Is this relevant?